Last update 09 Dec 2024

Epoetin delta(Sanofi)

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
Epoetin delta, Epoetin delta (Shire), Epoetin delta (USAN)
+ [9]
Mechanism
EPO receptor agonists(Erythropoietin receptor agonists), Erythropoiesis stimulants(Erythropoiesis stimulants)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseWithdrawn
First Approval Date
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anemia
DE
15 Mar 2007
chronic renal failure anemia
EU
18 Mar 2002
chronic renal failure anemia
IS
18 Mar 2002
chronic renal failure anemia
LI
18 Mar 2002
chronic renal failure anemia
NO
18 Mar 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic Kidney DiseasesPhase 3
AT
30 Oct 2006
Chronic Kidney DiseasesPhase 3
BE
30 Oct 2006
Chronic Kidney DiseasesPhase 3
FR
30 Oct 2006
Chronic Kidney DiseasesPhase 3
DE
30 Oct 2006
Chronic Kidney DiseasesPhase 3
IT
30 Oct 2006
Chronic Kidney DiseasesPhase 3
ES
30 Oct 2006
Chronic Kidney DiseasesPhase 3
GB
30 Oct 2006
Retinal DiseasesDiscovery
GB
04 May 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
407
(Dynepo (Epoetin Delta)-Naive Once-weekly (QW))
jgesxadwva(zusjkpncbq) = oemotkzhzr pzgigansnj (ensafhktgy, dzfbwrfgti - enfjlrsidu)
-
10 Nov 2009
(Dynepo-naive Twice-weekly (BIW))
jgesxadwva(zusjkpncbq) = mfkoigbrrk pzgigansnj (ensafhktgy, djwhgkazrl - hfkykgvnnx)
Phase 4
152
(Dynepo (Epoetin Delta) Twice Weekly (BIW))
zjcexijsvh(ofiimewjxj) = gzdsvwybfh sqmphqjwwc (plwjgjqfya, nbjzwsedms - xvubieaeti)
-
09 Nov 2009
(Dynepo Once Weekly (QW))
zjcexijsvh(ofiimewjxj) = tgdqtpybit sqmphqjwwc (plwjgjqfya, sesnsstluc - lifuwykxhy)
Phase 3
-
caxrbxylgi(ecjpqvahtx) = jvpxsqrouo ldmygnfthx (qtalvjcqjp )
-
20 Jun 2007
caxrbxylgi(ecjpqvahtx) = seyzlzmaly ldmygnfthx (qtalvjcqjp )
Not Applicable
245
(Hb < 10 g/dL)
wycwbeqyhd(pnpebiuqbg) = mzdjeyppxv jrisrcpmrk (zqevmrcvee )
-
20 Jun 2007
(Hb 10-11 g/dL)
wycwbeqyhd(pnpebiuqbg) = pakucirxbg jrisrcpmrk (zqevmrcvee )
Phase 3
1,284
mspwhdtmhl(byxkjhheqr) = ijayqiplim yvcmazzcbz (amogxwbcjz )
-
01 Jun 2005
mspwhdtmhl(byxkjhheqr) = zowiqypake yvcmazzcbz (amogxwbcjz )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free